Yorkshire Bioscience Ltd

Yorkshire Bioscience Ltd, based in York, UK, is a small, active company established 21 years ago in 2004. With just two employees and £172,885 in assets, it operates from a real address and is overseen by one director and owner. The company is an irregular importer, primarily dealing in optical and medical tools and devices, with the last import activity recorded two months ago in February 2022.

The company's website, YoBio RD, positions itself as a provider of research and customer services for the life science community, both within the UK and worldwide. It offers a wide range of services, including peptide and protein synthesis, gene synthesis, DNA cloning, antibody production, and virus packaging. The website highlights its key strength: strong support from UK biotechnology development organizations and a worldwide network of skilled scientists. It's clear they're aiming to be a one-stop shop for laboratory work, offering everything from cell biology services to custom RNA production.

Financially, Yorkshire Bioscience Ltd presents a mixed picture. While current assets increased by 24% to £170,000, net assets declined by 11% to -£150,000, indicating a growing deficit. Bank borrowings increased significantly, reaching £320,000, and cash reserves fell to £820. Creditors also rose by 18%, suggesting a reliance on external financing. The company's small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) allows for flexibility, but the negative equity and rising debt are concerning. As a small company, it’s exempt from an audit, so these figures are unaudited. It’s likely the company is burning through cash to invest in its services and network, but the trend needs to be watched closely.

Registered in England/Wales under the registration number 05007025, with a registered address at YO31 0AA, England, York, 63-65 Heworth Road Heworth Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.